{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-011901","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.770427+00:00","generated_at":"2026-05-31T10:03:21.426285+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Helius Medical Q2 revenue $182K (down 29% YoY); secures first insurance reimbursement for PoNS at $23,900","bullets":["Revenue $182K vs $256K YoY due to PTAP termination; up 35% sequentially from Q1 2024.","Net loss $1.6M flat YoY; EPS -$0.64 vs -$2.92; cash $6.4M, no debt, runway into 2025.","First third-party insurance reimbursement secured at $23,900 for PoNS; CMS final rate due Oct 1.","Completed enrollment in stroke registrational program; FDA submission targeted H1 2025.","VA and DoD contract prices set at ~$23,800/$7,300 for device/mouthpiece; VA sales build underway."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-011901","json":"https://secwatch.observer/filing/0001558370-24-011901.json","markdown":"https://secwatch.observer/filing/0001558370-24-011901.md","text":"https://secwatch.observer/filing/0001558370-24-011901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024011901/0001558370-24-011901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000155837024011901/hsdt-20240812x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:03:21.426285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}